Giant cell tumour of bone in the rib cage treated with denosumab. A case report

被引:0
|
作者
Miralles, Paula Serret [1 ]
Fernandez, Ruth Orellana [1 ]
Parente, Tamara Parra [1 ]
Brigido, Rosa Belen Garcia-Chamon [1 ]
Salas, Ruben Carrera [1 ]
机构
[1] Univ Autonoma Barcelona, Parc Tauli Hosp Univ, Inst Invest Parc Tauli I3PT, Serv Patol, Sabadell, Spain
来源
REVISTA ESPANOLA DE PATOLOGIA | 2023年 / 56卷 / 02期
关键词
Giant cell tumour of bone; Denosumab;
D O I
10.1016/j.patol.2021.04.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Giant cell tumour of bone (GCTOB) accounts for 4-5% of all primary bone tumours and occurs most frequently in females between 20 and 45 years old. It is found in the epiphyses of the long bones, vertebral bodies and flat bones. We report the case of a 31-year-old woman who presented with a one month history of thoracic pain. On examination, a mass was found in the right breast with signs of an ipsilateral pleural effusion. A thoracic CAT scan revealed an infiltrating mass which was subsequently biopsied and a GCTOB was diagnosed. Due to the localization and the morphology, a wide range of differential diagnoses were considered. Genetic studies detected a mutation of the gene H3F3A, supporting the original diagnosis. The patient underwent treatment with denosumab followed by surgical resection of the mass. The histopathology of the tumour revealed various histological changes which were a source of diagnostic pitfalls. (c) 2021 Sociedad Espanola de Anatom<acute accent>& imath;a Patolo<acute accent>gica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Giant cell tumour successfully treated by denosumab
    Aubry-Rozier, B.
    Cherix, S.
    Ruediger, H. A.
    SWISS MEDICAL WEEKLY, 2013, 143 : 3S - 4S
  • [2] Giant cell tumour of bone in the denosumab era
    van der Heijden, Lizz
    Dijkstra, P. D. Sander
    Blay, Jean-Yves
    Gelderblom, Hans
    EUROPEAN JOURNAL OF CANCER, 2017, 77 : 75 - 83
  • [3] Denosumab treatment of giant cell tumour of bone
    Balke, Maurice
    LANCET ONCOLOGY, 2013, 14 (09): : 801 - 802
  • [4] Therapy of bone marrow edema syndrome in the knee with denosumab. Case report
    Geith, T.
    Mutschler, W.
    Berger, F.
    UNFALLCHIRURG, 2015, 118 (03): : 230 - 232
  • [5] Aggressive giant cell tumour of the mandible treated with denosumab
    Carey, B.
    Porter, S.
    Fedele, S.
    ORAL DISEASES, 2016, 22 : 42 - 43
  • [6] Denosumab for giant cell tumour of bone: success and limitations
    Healey, John H.
    LANCET ONCOLOGY, 2019, 20 (12): : 1627 - 1628
  • [7] Giant cell tumour of the bone under treatment with Denosumab
    Gama, J.
    Madeira, J.
    Oliveira, R.
    Faria, C.
    Almeida, V.
    Ramalhosa, F.
    Sepodes, B.
    Fontinha, G.
    Courelas, C.
    Alves, A.
    Cipriano, M. A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S339 - S339
  • [8] Safety of denosumab in giant-cell tumour of bone
    Thomas, David
    Carriere, Phillipe
    Jacobs, Ira
    LANCET ONCOLOGY, 2010, 11 (09): : 815 - 815
  • [9] Denosumab for an inoperable giant cell tumour of the ischial bone
    Paul, Aaron Gerarde
    See, Lei Peng
    Ohn, May Honey
    Ohn, Khin Maung
    BMJ CASE REPORTS, 2023, 16 (12)
  • [10] Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series
    Girolami, Ilaria
    Mancini, Irene
    Simoni, Antonella
    Baldi, Giacomo Giulio
    Simi, Lisa
    Campanacci, Domenico
    Beltrami, Giovanni
    Scoccianti, Guido
    D'Arienzo, Antonio
    Capanna, Rodolfo
    Franchi, Alessandro
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (03) : 240 - 247